Jun 01, 2020
CeloNova Announces Enrollment Completion of World's First Randomized Control, 14-Day DAPT Trial
May 20, 2020
OpSens - 100,000 Cases Performed with the OptoWire
May 12, 2020
Coronary Stent Market Size Worth $11.3 Billion By 2027 | CAGR: 4.7%: Grand View Research, Inc.
Apr 23, 2020
China Coronary Intervention (CI) & Percutaneous Coronary Intervention (PCI) Device Market, Forecast to 2024 - Growing Consumption of Fast Food, Rising PCI Prevalence, Increasing STEMI Patients
Jan 13, 2020
Opsens Receives FDA Approval of Optowire III
Jan 13, 2020
Mentice Showcases First-of-Its-Kind Flexible Coronary Training Solution at IMSH 2020
Dec 17, 2019
Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study
Dec 12, 2019
Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Dec 11, 2019
The $1.2 Billion Fractional Flow Reserve Market: Insights & Opportunity Assessment, 2019 to 2026
Nov 19, 2019
Faraday Pharmaceuticals Announces Positive Top-Line Results from Phase 2 Trial of FDY-5301 for Treatment of Reperfusion Injury Following a STEMI Heart Attack
Nov 16, 2019
ISCHEMIA-CKD Trial: Advanced Chronic Kidney Disease Patients Treated with Invasive Heart Procedures Show No Reduction in Rate of Cardiac Events
Nov 06, 2019
Coronary Stents Market Value to Hit $8 Billion by 2025: Global Market Insights, Inc.
Sep 30, 2019
Neovasc's Tiara(TM) for Treatment of Mitral Regurgitation and Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Multiple Presentations at TCT 2019 Conference
Sep 26, 2019
Coronary Stent Patients May Not Need Long-Term Aspirin - Mount Sinai
Sep 26, 2019
Aspirin Continues to be the Gold Standard Treatment for Millions of Americans Who Have Had a Cardiovascular Event
Sep 04, 2019
New Study Shows EarlySign's Machine Learning Algorithm Can Predict Which Cardiac Patients are at High-Risk Following Discharge
Sep 03, 2019
Superiority of Orsiro over Xience Demonstrated in STEMI Patients: Late-Breaking Data at ESC
Aug 19, 2019
Global Coronary Stents Market to 2023: Product Launches / Bioresorbable Coronary Stents / Mergers and Acquisitions / Technological Advancements
Aug 06, 2019
CeloNova Announces Appointment of New President and CEO
Jul 23, 2019
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent